Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tissues and Tumor Microenvironment (TME) in 3D: Models to Shed Light on Immunosuppression in Cancer. | Cells | 2021 | 33917037 | PubTator, text mining | PubMed |
| Secretion rates and protein composition of extracellular vesicles released by cancer-associated fibroblasts after radiation. | J Radiat Res | 2021 | 33899109 | PubTator, text mining | PubMed |
| Chemically Engineered Immune Cell-Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools. | Adv Sci (Weinh) | 2021 | 33898169 | PubTator, text mining | PubMed |
| Multiply restimulated human thymic regulatory T cells express distinct signature regulatory T-cell transcription factors without evidence of exhaustion. | Cytotherapy | 2021 | 33893050 | PubTator, text mining | PubMed |
| Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions. | Front Oncol | 2021 | 33869061 | PubTator, text mining | PubMed |
| Bioinformatics and survival analysis of glia maturation factor-γ in pan-cancers. | BMC Cancer | 2021 | 33863293 | PubTator, text mining | PubMed |
| Cancer Vaccines, Adjuvants, and Delivery Systems. | Front Immunol | 2021 | 33859638 | PubTator, text mining | PubMed |
| Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma. | Leuk Lymphoma | 2021 | 33856277 | PubTator, text mining | PubMed |
| Profiles of alternative splicing events in the diagnosis and prognosis of Gastric Cancer. | J Cancer | 2021 | 33854599 | PubTator, text mining | PubMed |
| Pure erythroid leukemia subsequent to acute myelomonocytic leukemia: A case report. | Medicine (Baltimore) | 2021 | 33847676 | PubTator, text mining | PubMed |
| CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia. | Ann Hematol | 2021 | 33822276 | PubTator, text mining | PubMed |
| Belatacept in renal transplantation in comparison to tacrolimus and molecular understanding of resistance pattern: Meta-analysis and systematic review. | World J Transplant | 2021 | 33816147 | PubTator, text mining | PubMed |
| Progression of Metastasis through Lymphatic System. | Cells | 2021 | 33808959 | PubTator, text mining | PubMed |
| EBV and the Pathogenesis of NK/T Cell Lymphoma. | Cancers (Basel) | 2021 | 33808787 | PubTator, text mining | PubMed |
| Adapter Chimeric Antigen Receptor (AdCAR)-Engineered NK-92 Cells for the Multiplex Targeting of Bone Metastases. | Cancers (Basel) | 2021 | 33807875 | PubTator, text mining | PubMed |
Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies. | J Fungi (Basel) | 2021 | 33807678 | PubTator, text mining | PubMed |
| The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy. | Biomedicines | 2021 | 33807260 | PubTator, text mining | PubMed |
| Chordoma-Current Understanding and Modern Treatment Paradigms. | J Clin Med | 2021 | 33806339 | PubTator, text mining | PubMed |
| Extracellular Vesicles and Their Role in the Spatial and Temporal Expansion of Tumor-Immune Interactions. | Int J Mol Sci | 2021 | 33806053 | PubTator, text mining | PubMed |
| Engaging the Innate and Adaptive Antitumor Immune Response in Lymphoma. | Int J Mol Sci | 2021 | 33804869 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=47